Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, Lopez-Vergès S, Lanier LL, Weisdorf D, Miller JS.

Blood. 2012 Mar 15;119(11):2665-74. doi: 10.1182/blood-2011-10-386995. Epub 2011 Dec 16.

2.

Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.

Della Chiesa M, Falco M, Bertaina A, Muccio L, Alicata C, Frassoni F, Locatelli F, Moretta L, Moretta A.

J Immunol. 2014 Feb 15;192(4):1471-9. doi: 10.4049/jimmunol.1302053. Epub 2014 Jan 17.

3.

Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.

Horowitz A, Guethlein LA, Nemat-Gorgani N, Norman PJ, Cooley S, Miller JS, Parham P.

J Immunol. 2015 Nov 1;195(9):4524-36. doi: 10.4049/jimmunol.1401990. Epub 2015 Sep 28.

PMID:
26416275
4.

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, Nixon DF, Lanier LL.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32. doi: 10.1073/pnas.1110900108. Epub 2011 Aug 8.

5.

Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.

Charoudeh HN, Terszowski G, Czaja K, Gonzalez A, Schmitter K, Stern M.

Eur J Immunol. 2013 Feb;43(2):480-7. doi: 10.1002/eji.201242389. Epub 2012 Dec 12.

6.

Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.

Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Bravo D, Clari MÁ, Navarro D.

J Med Virol. 2012 Feb;84(2):259-67. doi: 10.1002/jmv.22254.

PMID:
22170546
7.

Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.

Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, Anasetti C, Weisdorf D, Miller JS.

J Immunol. 2012 Nov 15;189(10):5082-8. doi: 10.4049/jimmunol.1201964. Epub 2012 Oct 17.

8.

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.

Davis ZB, Cooley SA, Cichocki F, Felices M, Wangen R, Luo X, DeFor TE, Bryceson YT, Diamond DJ, Brunstein C, Blazar BR, Wagner JE, Weisdorf DJ, Horowitz A, Guethlein LA, Parham P, Verneris MR, Miller JS.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1653-62. doi: 10.1016/j.bbmt.2015.05.025. Epub 2015 Jun 6.

PMID:
26055301
9.

Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells.

Djaoud Z, David G, Bressollette C, Willem C, Rettman P, Gagne K, Legrand N, Mehlal S, Cesbron A, Imbert-Marcille BM, Retière C.

J Immunol. 2013 Sep 1;191(5):2708-16. doi: 10.4049/jimmunol.1301138. Epub 2013 Aug 5.

10.

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

Hadaya K, de Rham C, Bandelier C, Bandelier C, Ferrari-Lacraz S, Jendly S, Berney T, Buhler L, Kaiser L, Seebach JD, Tiercy JM, Martin PY, Villard J.

Am J Transplant. 2008 Dec;8(12):2674-83. doi: 10.1111/j.1600-6143.2008.02431.x.

11.

Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.

Giménez E, Solano C, Amat P, de la Cámara R, Nieto J, López J, Garcia-Noblejas A, Navarro D.

J Med Virol. 2015 Sep;87(9):1601-7. doi: 10.1002/jmv.24198. Epub 2015 Mar 19.

PMID:
25802229
12.

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

Béziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, Hervier B, Theodorou I, Martinot M, Debré P, Björkström NK, Malmberg KJ, Marcellin P, Vieillard V.

Eur J Immunol. 2012 Feb;42(2):447-57. doi: 10.1002/eji.201141826. Epub 2011 Dec 16.

13.

An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.

Muñoz-Cobo B, Giménez E, Solano C, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Navarro D.

J Med Virol. 2014 May;86(5):806-11. doi: 10.1002/jmv.23742. Epub 2013 Sep 16.

PMID:
24105728
14.

Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.

Hendricks DW, Balfour HH Jr, Dunmire SK, Schmeling DO, Hogquist KA, Lanier LL.

J Immunol. 2014 May 15;192(10):4492-6. doi: 10.4049/jimmunol.1303211. Epub 2014 Apr 16.

15.

CMV induces rapid NK cell maturation in HSCT recipients.

Della Chiesa M, Muccio L, Moretta A.

Immunol Lett. 2013 Sep-Oct;155(1-2):11-3. doi: 10.1016/j.imlet.2013.09.020. Epub 2013 Sep 26. Review.

PMID:
24076315
16.

Multiplex and genome-wide analyses reveal distinctive properties of KIR+ and CD56+ T cells in human blood.

Chan WK, Rujkijyanont P, Neale G, Yang J, Bari R, Das Gupta N, Holladay M, Rooney B, Leung W.

J Immunol. 2013 Aug 15;191(4):1625-36. doi: 10.4049/jimmunol.1300111. Epub 2013 Jul 15.

17.

Spotlight on NKG2C and the human NK-cell response to CMV infection.

Malmberg KJ, Beziat V, Ljunggren HG.

Eur J Immunol. 2012 Dec;42(12):3141-5. doi: 10.1002/eji.201243050.

18.

Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection.

Björkström NK, Svensson A, Malmberg KJ, Eriksson K, Ljunggren HG.

PLoS One. 2011;6(11):e27664. doi: 10.1371/journal.pone.0027664. Epub 2011 Nov 15.

19.

Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.

Wu Z, Sinzger C, Frascaroli G, Reichel J, Bayer C, Wang L, Schirmbeck R, Mertens T.

J Virol. 2013 Jul;87(13):7717-25. doi: 10.1128/JVI.01096-13. Epub 2013 May 1.

20.

Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.

Martínez-Rodríguez JE, Munné-Collado J, Rasal R, Cuadrado E, Roig L, Ois A, Muntasell A, Baro T, Alameda F, Roquer J, López-Botet M.

Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2653-9. doi: 10.1161/ATVBAHA.113.302163. Epub 2013 Aug 22.

Items per page

Supplemental Content

Write to the Help Desk